<DOC>
	<DOCNO>NCT01353989</DOCNO>
	<brief_summary>A lot elderly people travel hepatitis A endemic area . The prevalence hepatitis A IgG positivity decline Netherlands , also elderly . Studies show people 40 year age slow immune response hepatitis A vaccination . However , lot traveler seek pre-travel advice shortly journey . More information time adequate antibody response hepatitis A vaccination require provide good protection travel . Alternative protection immunoglobulin available . Study design : Observational , longitudinal pilot study Study population : 20 adult 60 year age negative hepatitis A IgG , ( estimate 50 % positivity hepatitis A IgG age Group , 40 patient age group ) 20 adults 18-40 year age control . Intervention ( applicable ) : When hepatitis A vaccination indicate informed consent obtain , hepatitis A IgG wil measure day 0 , 7 , 14 , 21 en 28 . Main study parameters/endpoints : Time protective hepatitis A IgG . Nature extent burden risk associate participation , benefit group relatedness : hepatitis A vaccination give also outside study . In study 5 venous puncture 7 ml blood .</brief_summary>
	<brief_title>Hepatitis A Vaccination Elderly</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>previous hep A vaccination know hepatitis A serology status immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>hepatitis A</keyword>
	<keyword>vaccination</keyword>
	<keyword>elderly</keyword>
	<keyword>protection hepatitis A vaccination</keyword>
</DOC>